Capricor Therapeutics Inc. (NASDAQ: CAPR)
$13.1100
+0.0400 ( -0.46% ) 0.1K
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Market Data
Open
$13.1100
Previous close
$13.0700
Volume
0.1K
Market cap
$594.29M
Day range
$13.0850 - $13.1700
52 week range
$3.5200 - $23.4000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 16, 2024 |
| 4 | Insider transactions | 1 | Dec 04, 2024 |
| 10-q | Quarterly Reports | 59 | Nov 14, 2024 |
| 8-k | 8K-related | 15 | Nov 13, 2024 |
| 8-k | 8K-related | 18 | Oct 17, 2024 |
| 8-k | 8K-related | 13 | Oct 16, 2024 |
| 8-k | 8K-related | 15 | Oct 09, 2024 |
| 4 | Insider transactions | 1 | Sep 24, 2024 |
| 8-k | 8K-related | 32 | Sep 24, 2024 |
| 8-k | 8K-related | 18 | Sep 17, 2024 |